Research and analysis

Laboratory reports of hepatitis C infections in England and Wales: July to September 2024

Published 27 February 2025

Applies to England and Wales

Between July and September, a total of 3,300 laboratory reports of hepatitis C were reported to UKHSA.

There was a 2% decrease in the number of reports compared to the third quarter of 2023 (n=3,239).

Since 2017, one laboratory in the North West of England has undertaken hepatitis C dried blood spot testing alongside hepatitis C routine laboratory testing. This single laboratory has taken on testing for a large part of the country; however, some samples where geographical information is lacking, may have been incorrectly assigned to this specific laboratory rather than the laboratory from which the sample originated.

Age and sex were well reported (99% complete). Where sex was known, males accounted for 64% of reports (2,116 out of 3,3009) which is consistent than previous quarters and years. Adults aged 35 to 44 years accounted for 26% of the total number of hepatitis C reports.

Table 1. Laboratory reports of hepatitis C in England and Wales, July to September 2024*

Age group Males Females Unknown Total
1 to 4 years 2   2   1   5
5 to 9 years 0   2   0   2
10 to 14 years 1   0   0   1
15 to 24 years 51   34   11   96
25 to 34 years 281   170   13   464
35 to 44 years 582   259   17   858
45 to 54 years 520   210   25   755
55 to 64 years 376   192   6   574
≥65 years 288   208   8   504
Unknown 15   5   21   41
Total 2,116   1,082    102    3,300

*Provisional data

Individuals aged under 1 year are excluded, since positive tests in this age group may reflect the presence of passively-acquired maternal antibody rather than true infection.

Laboratory reports are not reliable for differentiating acute and chronic hepatitis C infections. Laboratory reports include individuals with a positive test for hepatitis C antibody, antigen and/or detection of hepatitis C RNA.

A small proportion of these specimens are diagnosed following dried blood spot (DBS) testing; however, not all DBS testing is reported by laboratories.

In Table 2, laboratory reports are presented broken down by Operational Delivery Network (ODN). ODNs were launched in September 2013 following the publication of the NHS England strategy to sustain and develop clinical networks.

ODNs are the networks through which hepatitis C treatment is being delivered across England. Between July and September 2024, 2,625 out of 3,300 individuals in England had been allocated to an ODN.

Table 2. Laboratory reports of hepatitis C by Operational Delivery Network, July to September 2024*

Primary ODN Total
Barts 209
Birmingham 196
Bristol and Severn 109
Cheshire and Merseyside 96
Eastern Hepatitis Network 106
Greater Manchester and Eastern Cheshire 238
Humberside and North Yorkshire 37
Kent Network via Kings 42
Lancashire and South Cumbria 103
Leicester 63
North Central London 118
North East and Cumbria 185
Nottingham 128
South Thames Hepatitis Network 175
South West Peninsula 70
South Yorkshire 70
Surrey Hepatitis Services 92
Sussex Hepatology Network 87
Thames Valley Hep C ODN 33
Wessex Hep C ODN 96
West London 278
West Yorkshire 94

*Provisional data

ODNs are based on NHS England Clinical Commissioning Groups (CCGs) geographic boundaries. NHS England allocates a primary or lead ODN for CCGs which may cross more two ODNs.